Showing 757 to 768 of 2,622 results


Florida Poised to Ban Fluoride in Public Drinking Water
Florida's legislature approved a bill banning fluoride and other additives in public drinking water, defying dental and public health experts who cite cavity prevention benefits; the bill awaits the governor's signature, following Utah's similar ban.
Florida Poised to Ban Fluoride in Public Drinking Water
Florida's legislature approved a bill banning fluoride and other additives in public drinking water, defying dental and public health experts who cite cavity prevention benefits; the bill awaits the governor's signature, following Utah's similar ban.
Progress
52% Bias Score


Italian Cities Exceed Air Quality Limits in First Quarter of 2025
During the first quarter of 2025, Italian cities like Padova, Milan, Brescia, and Turin exceeded EU and WHO limits for PM2.5 by a significant margin (52, 51, 50, and 48 days respectively), while Palermo, Naples, Messina, and Genoa showed high nitrogen dioxide levels.
Italian Cities Exceed Air Quality Limits in First Quarter of 2025
During the first quarter of 2025, Italian cities like Padova, Milan, Brescia, and Turin exceeded EU and WHO limits for PM2.5 by a significant margin (52, 51, 50, and 48 days respectively), while Palermo, Naples, Messina, and Genoa showed high nitrogen dioxide levels.
Progress
44% Bias Score


Florida Poised to Ban Fluoride in Public Drinking Water
Florida's legislature passed a bill banning fluoride in public drinking water, following Utah's similar ban, despite concerns from dentists and public health advocates who cite the mineral's effectiveness in preventing cavities. The bill awaits Governor DeSantis's signature.
Florida Poised to Ban Fluoride in Public Drinking Water
Florida's legislature passed a bill banning fluoride in public drinking water, following Utah's similar ban, despite concerns from dentists and public health advocates who cite the mineral's effectiveness in preventing cavities. The bill awaits Governor DeSantis's signature.
Progress
56% Bias Score


NSW's $540M Mental Health Facility Faces Staffing Crisis
Construction began Wednesday on a $540 million mental health facility in western Sydney, projected to open in 2027, but psychiatrists warn severe staff shortages—with over a third of public sector positions vacant—will leave it underutilized, mirroring issues faced by other recently opened facilitie...
NSW's $540M Mental Health Facility Faces Staffing Crisis
Construction began Wednesday on a $540 million mental health facility in western Sydney, projected to open in 2027, but psychiatrists warn severe staff shortages—with over a third of public sector positions vacant—will leave it underutilized, mirroring issues faced by other recently opened facilitie...
Progress
56% Bias Score


Hamburg CDU Demands Repeal of German Cannabis Legalization
Hamburg's CDU calls for a reversal of Germany's one-year-old cannabis legalization due to unmet cost-saving projections, increased drug-related issues, and the Senate's acknowledgement of policy failure, urging the Senate to initiate a federal repeal.
Hamburg CDU Demands Repeal of German Cannabis Legalization
Hamburg's CDU calls for a reversal of Germany's one-year-old cannabis legalization due to unmet cost-saving projections, increased drug-related issues, and the Senate's acknowledgement of policy failure, urging the Senate to initiate a federal repeal.
Progress
60% Bias Score


U.S. Diabetes Deaths Decline After COVID-19 Surge
Preliminary CDC data reveals a decrease in U.S. diabetes deaths to 26.4 per 100,000 in the third quarter of 2024, down from a 2021 peak of 31.1, potentially due to reduced COVID-19 impact and improved management, though rates remain above pre-pandemic levels.
U.S. Diabetes Deaths Decline After COVID-19 Surge
Preliminary CDC data reveals a decrease in U.S. diabetes deaths to 26.4 per 100,000 in the third quarter of 2024, down from a 2021 peak of 31.1, potentially due to reduced COVID-19 impact and improved management, though rates remain above pre-pandemic levels.
Progress
12% Bias Score

FDA Reviews COVID-19 Vaccine Approvals for Next Winter Amid Data Concerns
The FDA is reviewing whether to approve COVID-19 vaccines for next winter due to insufficient data on booster shot effectiveness and low uptake, marking a shift from the previous administration's policy of annual updates.

FDA Reviews COVID-19 Vaccine Approvals for Next Winter Amid Data Concerns
The FDA is reviewing whether to approve COVID-19 vaccines for next winter due to insufficient data on booster shot effectiveness and low uptake, marking a shift from the previous administration's policy of annual updates.
Progress
44% Bias Score

EU Warns of Rising Infectious Diseases Due to Low Vaccination Rates
The European Union issued a warning about rising measles and polio cases due to suboptimal vaccination coverage; over 35,000 measles cases and 23 deaths were reported in 2024 across the EU, while poliovirus was detected in wastewater in several countries, highlighting the urgent need for improved va...

EU Warns of Rising Infectious Diseases Due to Low Vaccination Rates
The European Union issued a warning about rising measles and polio cases due to suboptimal vaccination coverage; over 35,000 measles cases and 23 deaths were reported in 2024 across the EU, while poliovirus was detected in wastewater in several countries, highlighting the urgent need for improved va...
Progress
20% Bias Score

China's White Paper: COVID-19 Origins Tracing and US Response Criticized
China released a white paper Wednesday detailing its cooperation with the WHO in COVID-19 origin tracing, refuting the Wuhan lab leak theory, and criticizing the US response, suggesting earlier US outbreak and demanding investigation.

China's White Paper: COVID-19 Origins Tracing and US Response Criticized
China released a white paper Wednesday detailing its cooperation with the WHO in COVID-19 origin tracing, refuting the Wuhan lab leak theory, and criticizing the US response, suggesting earlier US outbreak and demanding investigation.
Progress
60% Bias Score

Halozyme Sues Merck Over Injectable Keytruda
Merck's new injectable Keytruda faces a lawsuit from Halozyme, delaying its planned October 1 launch and highlighting upcoming patent expirations in 2028. The suit challenges Merck's use of Halozyme's hyaluronidase technology in the new injectable formulation, and Merck has said it is meritless.

Halozyme Sues Merck Over Injectable Keytruda
Merck's new injectable Keytruda faces a lawsuit from Halozyme, delaying its planned October 1 launch and highlighting upcoming patent expirations in 2028. The suit challenges Merck's use of Halozyme's hyaluronidase technology in the new injectable formulation, and Merck has said it is meritless.
Progress
40% Bias Score

Family Urges HPV Vaccination After Daughter's Death
The family of a 25-year-old woman who died from cervical cancer in 2012 due to HPV are urging parents to vaccinate their children after the virus was found to be responsible for her death. The HPV vaccine has been available in the UK since 2008 for girls and 2019 for boys.

Family Urges HPV Vaccination After Daughter's Death
The family of a 25-year-old woman who died from cervical cancer in 2012 due to HPV are urging parents to vaccinate their children after the virus was found to be responsible for her death. The HPV vaccine has been available in the UK since 2008 for girls and 2019 for boys.
Progress
48% Bias Score

German District Takes Over Hospitals Amidst Healthcare Concerns
The Uckermark district in Germany will assume direct control of its two hospitals in Prenzlau and Angermünde after a €2 million bailout failed to resolve financial issues and concerns about patient care under the current management, Gesellschaft für Leben und Gesundheit (GLG).

German District Takes Over Hospitals Amidst Healthcare Concerns
The Uckermark district in Germany will assume direct control of its two hospitals in Prenzlau and Angermünde after a €2 million bailout failed to resolve financial issues and concerns about patient care under the current management, Gesellschaft für Leben und Gesundheit (GLG).
Progress
48% Bias Score
Showing 757 to 768 of 2,622 results